Literature DB >> 24878052

Adrenal function after adrenalectomy for subclinical hypercortisolism and Cushing's syndrome: a systematic review of the literature.

Guido Di Dalmazi1, Christina M Berr, Martin Fassnacht, Felix Beuschlein, Martin Reincke.   

Abstract

CONTEXT: The postoperative course of patients with subclinical hypercortisolism (SH) is yet to be clarified. The aims are to review the prevalence and predictive factors of postoperative adrenal insufficiency and the time to recover a normal adrenocortical function in patients with SH and Cushing's syndrome (CS). EVIDENCE ACQUISITION: Using the PubMed database, we conducted a systematic review of the literature, selecting studies published from 1980 to 2013. EVIDENCE SYNTHESIS: Of the 1522 papers screened, 28 were selected (13 retrospective, 14 prospective, and one randomized controlled trial). The prevalence of postoperative adrenal insufficiency was 65.3% in 248 SH subjects and 99.7% in 377 CS patients. Patients with SH were reclassified according to the following diagnostic criteria: subjects defined by pathological dexamethasone test only (DEX), and those defined by the dexamethasone test with one (DEX+1) or two additional criteria (DEX+2); and they were compared with CS patients. The prevalence of adrenal insufficiency was 51.4, 60.6, 91.3, and 99.7%, respectively, with no significant difference between the two latter groups. The test with the best compromise between sensitivity (64%) and specificity (81%) in predicting adrenal insufficiency was the midnight serum cortisol. The time to achieve eucortisolism was lower in SH patients than in CS patients (6.5 vs 11.2 mo; P < .001).
CONCLUSIONS: Adrenal insufficiency occurs in about half of the patients with SH if defined only by the pathological dexamethasone test. However, prevalence of adrenal insufficiency and time to recovery are tightly related to the degree of hypercortisolism and diagnostic criteria to define SH, which might help to better define SH for future studies.

Entities:  

Mesh:

Year:  2014        PMID: 24878052     DOI: 10.1210/jc.2014-1401

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  26 in total

1.  Factors predicting the duration of adrenal insufficiency in patients successfully treated for Cushing disease and nonmalignant primary adrenal Cushing syndrome.

Authors:  Alessandro Prete; Rosa Maria Paragliola; Filomena Bottiglieri; Carlo Antonio Rota; Alfredo Pontecorvi; Roberto Salvatori; Salvatore Maria Corsello
Journal:  Endocrine       Date:  2016-07-09       Impact factor: 3.633

2.  Extensive clinical experience: Hypothalamic-pituitary-adrenal axis recovery after adrenalectomy for corticotropin-independent cortisol excess.

Authors:  Maria Daniela Hurtado; Tiffany Cortes; Neena Natt; William F Young; Irina Bancos
Journal:  Clin Endocrinol (Oxf)       Date:  2018-07-23       Impact factor: 3.478

3.  Six controversial issues on subclinical Cushing's syndrome.

Authors:  Iacopo Chiodini; Adriana Albani; Alberto Giacinto Ambrogio; Michela Campo; Maria Cristina De Martino; Giorgia Marcelli; Valentina Morelli; Benedetta Zampetti; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2016-07-12       Impact factor: 3.633

4.  QT interval instability and variability in dogs with naturally-occurring hypercortisolism.

Authors:  Beatriz de Carvalho Pato Vila; Marcela Sigolo Vanhoni; Marlos Gonçalves Sousa
Journal:  Vet Res Commun       Date:  2022-05-16       Impact factor: 2.459

5.  Factors predicting prolonged glucocorticoid therapy in patients with adrenal insufficiency after laparoscopic adrenalectomy.

Authors:  Francesco Ziglioli; Simona Cataldo; Domenico Maria Cavalieri; Davide Campobasso; Umberto Maestroni
Journal:  Ann Med Surg (Lond)       Date:  2022-03-10

6.  The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System.

Authors:  Emanuel Raschi; Michele Fusaroli; Francesco Massari; Veronica Mollica; Andrea Repaci; Andrea Ardizzoni; Elisabetta Poluzzi; Uberto Pagotto; Guido Di Dalmazi
Journal:  J Clin Endocrinol Metab       Date:  2022-07-14       Impact factor: 6.134

7.  Predictability of hypoadrenalism occurrence and duration after adrenalectomy for ACTH-independent hypercortisolism.

Authors:  V Morelli; L Minelli; C Eller-Vainicher; S Palmieri; E Cairoli; A Spada; M Arosio; I Chiodini
Journal:  J Endocrinol Invest       Date:  2017-11-18       Impact factor: 4.256

8.  Cushing's syndrome: comparison between Cushing's disease and adrenal Cushing's.

Authors:  Dania Hirsch; Ilan Shimon; Yossi Manisterski; Nirit Aviran-Barak; Oren Amitai; Varda Nadler; Sandra Alboim; Vered Kopel; Gloria Tsvetov
Journal:  Endocrine       Date:  2018-08-06       Impact factor: 3.633

Review 9.  Cardiovascular risk and mortality in patients with active and treated hypercortisolism.

Authors:  Dingfeng Li; Omar M El Kawkgi; Andres F Henriquez; Irina Bancos
Journal:  Gland Surg       Date:  2020-02

10.  The epidemiology of primary and secondary adrenal malignancies and associated adrenal insufficiency in hospitalised patients: an analysis of hospital admission data, NSW, Australia.

Authors:  Anna Lubomski; Henrik Falhammar; David J Torpy; R Louise Rushworth
Journal:  BMC Endocr Disord       Date:  2021-07-03       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.